EUPRAXIA PHARMACEUTICALS INC. Convertible Debt, Current
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Convertible Debt, Current of $10.34 million as of 2023-12-31, per its 40-F filed 2025-03-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2025-03-20
- 2023-12-31: Convertible Debt, Current $10.34M.
| Period end | Convertible Debt, Current |
|---|---|
| 2023-12-31 | $10.34M 40-F · filed 2025-03-20 |